In silico screening of HIV-1 non-nucleoside reverse transcriptase and protease inhibitors
- 31 July 2008
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 43 (7) , 1412-1422
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Streamlining lead discovery by aligning in silico and high-throughput screeningCurrent Opinion in Chemical Biology, 2006
- Minimizing false positives in kinase virtual screensProteins: Structure, Function, and Bioinformatics, 2006
- SciFinder Scholar 2006: An Empirical Analysis of Research Topic Query ProcessingJournal of Chemical Information and Modeling, 2006
- Hierarchical Database Screenings for HIV-1 Reverse Transcriptase Using a Pharmacophore Model, Rigid Docking, Solvation Docking, and MM−PB/SAJournal of Medicinal Chemistry, 2005
- Virtual Screening Using Protein−Ligand Docking: Avoiding Artificial EnrichmentJournal of Chemical Information and Computer Sciences, 2004
- Synthesis and primary cytotoxicity evaluation of 3-[[(3-phenyl-4(3H)-quinazolinone-2-yl)mercaptoacetyl]hydrazono]-1H-2-indolinonesEuropean Journal of Medicinal Chemistry, 2003
- Design, Synthesis, and Biological Evaluation of Monopyrrolinone-Based HIV-1 Protease InhibitorsJournal of Medicinal Chemistry, 2003
- The Protein Data BankNucleic Acids Research, 2000
- Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997
- A Fast Flexible Docking Method using an Incremental Construction AlgorithmJournal of Molecular Biology, 1996